233 related articles for article (PubMed ID: 12444505)
21. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
[TBL] [Abstract][Full Text] [Related]
22. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
23. Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.
Chotibut T; Apple DM; Jefferis R; Salvatore MF
PLoS One; 2012; 7(12):e52322. PubMed ID: 23300642
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of Zn2(+)-sensitive GABA transporter expressed in primary cultures of astrocytes from rat cerebral cortex.
Wu Q; Wada M; Shimada A; Yamamoto A; Fujita T
Brain Res; 2006 Feb; 1075(1):100-9. PubMed ID: 16466645
[TBL] [Abstract][Full Text] [Related]
25. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
26. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells.
Horvath G; Sutto Z; Torbati A; Conner GE; Salathe M; Wanner A
Am J Physiol Lung Cell Mol Physiol; 2003 Oct; 285(4):L829-37. PubMed ID: 12807698
[TBL] [Abstract][Full Text] [Related]
27. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
Rothman RB; Clark RD; Partilla JS; Baumann MH
J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
[TBL] [Abstract][Full Text] [Related]
28. Sodium-independent transport of noradrenaline in mouse and rat astrocytes in primary culture.
Paterson IA; Hertz L
J Neurosci Res; 1989 May; 23(1):71-7. PubMed ID: 2746699
[TBL] [Abstract][Full Text] [Related]
29. Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons.
Yodoya E; Wada M; Shimada A; Katsukawa H; Okada N; Yamamoto A; Ganapathy V; Fujita T
J Neurochem; 2006 Apr; 97(1):162-73. PubMed ID: 16524379
[TBL] [Abstract][Full Text] [Related]
30. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
Diniz PH; Silva JH; Gomez MV; Guatimosim C; Gomez RS
Cell Mol Neurobiol; 2007 Sep; 27(6):757-70. PubMed ID: 17680357
[TBL] [Abstract][Full Text] [Related]
31. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation.
Backs J; Haunstetter A; Gerber SH; Metz J; Borst MM; Strasser RH; Kübler W; Haass M
J Mol Cell Cardiol; 2001 Mar; 33(3):461-72. PubMed ID: 11181015
[TBL] [Abstract][Full Text] [Related]
32. Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters.
Zhang S; Zhen J; Reith ME; Dutta AK
Bioorg Med Chem; 2004 Dec; 12(23):6301-15. PubMed ID: 15519172
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Zhu MY; Shamburger S; Li J; Ordway GA
J Pharmacol Exp Ther; 2000 Dec; 295(3):951-9. PubMed ID: 11082428
[TBL] [Abstract][Full Text] [Related]
35. Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activity.
Feigenbaum J; Yanai J; Klawans H; Moon B
Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):349-52. PubMed ID: 6844751
[TBL] [Abstract][Full Text] [Related]
36. [The role of glial monoamine transporters in the central nervous system].
Inazu M; Takeda H; Matsumiya T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Aug; 23(4):171-8. PubMed ID: 13677912
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
[TBL] [Abstract][Full Text] [Related]
38. Norepinephrine transporter function and desipramine: residual drug effects versus short-term regulation.
Ordway GA; Jia W; Li J; Zhu MY; Mandela P; Pan J
J Neurosci Methods; 2005 Apr; 143(2):217-25. PubMed ID: 15814154
[TBL] [Abstract][Full Text] [Related]
39. Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter.
Percy E; Kaye DM; Lambert GW; Gruskin S; Esler MD; Du XJ
Br J Pharmacol; 1999 Oct; 128(3):774-80. PubMed ID: 10516661
[TBL] [Abstract][Full Text] [Related]
40. Molecular and functional characterisation of glutamate transporters in rat cortical astrocytes exposed to a defined combination of growth factors during in vitro differentiation.
Vermeiren C; Najimi M; Maloteaux JM; Hermans E
Neurochem Int; 2005 Jan; 46(2):137-47. PubMed ID: 15627514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
